$37.425
0.085[0.23%]
Last update: 10:35AM Get Real Time Here
Soleno Therapeutics
(NASDAQ:SLNO)Latest News for Soleno Therapeutics Stock (NASDAQ:SLNO)
Soleno Therapeutics Stock (NASDAQ: SLNO)
Categories: All
Wednesday, March 06, 2024
Monday, February 05, 2024
Monday, January 29, 2024
Tuesday, January 23, 2024
Tuesday, January 02, 2024
Thursday, December 28, 2023
Tuesday, November 21, 2023
Tuesday, November 07, 2023
Monday, November 06, 2023
Friday, October 20, 2023
Friday, October 06, 2023
Wednesday, October 04, 2023
Friday, September 29, 2023
Thursday, September 28, 2023
- Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Sep 28, 2023, 1:04PM
- Soleno Therapeutics shares are trading higher. The company announced the pricing of a $60 million underwritten public offering of 3 million shares at $20 per share and a $60 million securities purchase agreement.Benzinga Newsdesk - Sep 28, 2023, 12:21PM
- Jabil, Chico's FAS And Other Big Stocks Moving Higher On ThursdayLisa Levin - Sep 28, 2023, 10:39AM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Sep 28, 2023, 9:05AM
- Soleno Therapeutics Announced Today The Pricing Of The $60M Underwritten Public Offering Of 3M Shares At $20/Share; Options To Purchase Up To 450,000 Shares At Public Offering Price; Enters Into $60M Securities Purchase AgreementBenzinga Newsdesk - Sep 28, 2023, 8:39AM
Wednesday, September 27, 2023
- Soleno Therapeutics Announces Proposed Public Offering Of Common Stock And/Or Pre-Funded Warrants; No Size Disclosed And A $30M Concurrent Private Placement Of Common Stock And/Or Pre-Funded WarrantsBenzinga Newsdesk - Sep 27, 2023, 4:10PM
- Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Sep 27, 2023, 12:48PM
Tuesday, September 26, 2023
- Soleno Therapeutics' Study Outcome Bolsters Confidence In PWS TreatmentVandana Singh - Sep 26, 2023, 3:18PM
- Nasdaq Down 1.5%; Immunovant Shares Spike HigherLisa Levin - Sep 26, 2023, 2:26PM
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Sep 26, 2023, 1:31PM
- Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Sep 26, 2023, 12:56PM
- Crude Oil Moves Higher; Cintas Earnings Top EstimatesLisa Levin - Sep 26, 2023, 12:04PM
- Cantor Fitzgerald Maintains Overweight on Soleno Therapeutics, Raises Price Target to $35Benzinga Newsdesk - Sep 26, 2023, 10:45AM
- Dow Tumbles 150 Points; US House Prices Rise in JulyLisa Levin - Sep 26, 2023, 9:46AM
- Soleno Therapeutics Shares Halted On Circuit Breaker To The Downside, Stock Now Up 318.5%Benzinga Newsdesk - Sep 26, 2023, 9:44AM
- Soleno Therapeutics Shares Resume TradeBenzinga Newsdesk - Sep 26, 2023, 9:42AM
- Soleno Therapeutics Shares Halted On Circuit Breaker To The Upside, Stock Now Up 383.1%Benzinga Newsdesk - Sep 26, 2023, 9:35AM
- Genetic Disorder Focused Soleno Therapeutics' Stock Is Trading 4X Today - Here's Why?Vandana Singh - Sep 26, 2023, 9:07AM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - Sep 26, 2023, 9:06AM
- Soleno Therapeutics shares are trading higher after the company released top-line results from randomized withdrawal period of study C602 of DCCR for Prader-Willi Syndrome.Benzinga Newsdesk - Sep 26, 2023, 9:00AM
- Market-Moving News for September 26thBenzinga Newsdesk - Sep 26, 2023, 8:34AM
- Soleno Therapeutics' DCCR Tablets Show Results in Long-Term Prader-Willi Syndrome StudyBenzinga Newsdesk - Sep 26, 2023, 7:35AM
Friday, September 15, 2023
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Sep 15, 2023, 1:31PM
- Oppenheimer Maintains Outperform Rating for Soleno Therapeutics: Here's What You Need To KnowBenzinga Insights - Sep 15, 2023, 1:00PM
- Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Sep 15, 2023, 12:40PM
- Oppenheimer Maintains Outperform on Soleno Therapeutics, Raises Price Target to $14Benzinga Newsdesk - Sep 15, 2023, 10:28AM
Thursday, August 31, 2023
Tuesday, August 08, 2023
Tuesday, July 11, 2023
- Keep The Hunger On: Analyst Says Soleno Therapeutics' Upside Potential Much Higher Than Downside RiskVandana Singh - Jul 11, 2023, 3:38PM
- Benzinga's Top Ratings Upgrades, Downgrades For July 11, 2023Benzinga Insights - Jul 11, 2023, 11:02AM
- Cantor Fitzgerald Initiates Coverage On Soleno Therapeutics with Overweight Rating, Announces Price Target of $19Benzinga Newsdesk - Jul 11, 2023, 8:38AM